A novel CAR T-cell therapy developed by researchers at UCL and designed to target cancerous tumors, has shown promising early results in children with neuroblastoma, a rare form of childhood cancer.
Nov 25, 2020
0
33
People with long-term exposure to air pollutants may be more likely to die from COVID-19, according to a new study.
Nov 4, 2020
1
56
Despite the remarkable successes of immune-based treatments for cancer, not everyone responds to these approaches and relapses do occur. Researchers around the world are racing to find ways to improve outcomes for people ...
Oct 21, 2020
0
46
Researchers at The University of Texas MD Anderson Cancer Center have identified molecular and cellular characteristics of anti-CD19 CAR T cell infusion products associated with how patients with large B-cell lymphoma (LBCL) ...
Oct 5, 2020
0
35
After an infection of the human body with a pathogen, a cascade of reactions will usually be set into motion. Amongst others, specific cells of the immune system known as T cells get activated in the lymph node and will subsequently ...
Sep 28, 2020
0
62
New research has uncovered the previously unknown presence of CD19—a B cell molecule targeted by chimeric antigen receptor (CAR) T cell immunotherapy to treat leukemia, lymphoma, and multiple myeloma—in brain cells that ...
Sep 21, 2020
0
86
City of Hope scientists have combined two potent immunotherapies—an oncolytic virus and chimeric antigen receptor (CAR) T cell therapy—to target and eradicate solid tumors that are otherwise difficult to treat with CAR ...
Sep 2, 2020
1
118
A recent study published in the journal Nature Medicine, led by researchers Todd Allen, Ph.D., a professor of Medicine at Harvard Medical School (HMS) and group leader at the Ragon Institute of MGH, MIT and Harvard, and Jim ...
Aug 31, 2020
0
60
CAR-T cell therapy is a new and revolutionary weapon against cancer: T cells are isolated from the patient's blood for genetic modification and then infused back into the patient to attack cancer cells. Researchers from the ...
Jul 7, 2020
0
107
Chimeric antigen receptor (CAR) T cells have transformed the treatment of refractory blood cancers. These genetically engineered immune cells seek out and destroy cancer cells with precision. Now, scientists at Memorial Sloan ...
Jun 17, 2020
0
142
